Profile

Micah Young

Chief Financial Officer and principal financial officer, QuidelOrtho Corporation

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Micah Young has been Chief Financial Officer and principal financial officer of QuidelOrtho Corporation since July 6, 2026, according to the company's filing of June 23, 2026.¹

The filing gives Micah Young's previous role as Executive Vice President and Chief Financial Officer at Masimo Corporation.¹ Micah Young joined from outside QuidelOrtho Corporation, by the record's reading of the filing.¹ The filing shows an earlier chief financial officer seat, so this is not Micah Young's first.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
QuidelOrtho Corporation (QDEL) In Vitro & In Vivo Diagnostic Substances	Chief Financial Officer and principal financial officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

July 6, 2026effective
QuidelOrtho Corporation appointed Micah Young as Chief Financial Officer and principal financial officer, effective July 6, 2026. Profile of Joseph M. Busky.
The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to serve as the Company’s Chief Financial Officer and principal financial officer, effective as of July 6, 2026 (the “Effective Date”).
[1] Filing by QuidelOrtho Corporation, filed with the SEC on June 23, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, QuidelOrtho Corporation. U.S. Securities and Exchange Commission, EDGAR, filed June 23, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Micah Young wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.